Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer

Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer

Patients diagnosed with locally advanced esophageal cancer are often treated with neoadjuvant chemoradiotherapy followed by surgery. This study explored whether detection of circulating tumor DNA (ctDNA) in plasma can be used to predict residual disease during treatment. Diagnostic tissue biopsies f...

Full description

Bibliographic Details
Main Authors: Lisa S. M. Hofste, Maartje J. Geerlings, Daniel von Rhein, Sofie H. Tolmeijer, Marjan M. Weiss, Christian Gilissen, Tom Hofste, Linda M. Garms, Marcel J. R. Janssen, Heidi Rütten, Camiel Rosman, Rachel S. van der Post, Bastiaan R. Klarenbeek, Marjolijn J. L. Ligtenberg
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
esophageal cancer
circulating tumor DNA
neoadjuvant treatment
liquid biopsies
next-generation sequencing
Online Access:https://www.mdpi.com/2072-6694/14/18/4417

Internet

https://www.mdpi.com/2072-6694/14/18/4417

Similar Items